Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration

Annals of Neurology

Volumn 71, Issue 6, 2012, Pages 815-824

  De Graaff, Esther ^a,b   Maat, Peter ^b   Hulsenboom, Esther ^b   Van Den Berg, Robert ^a,b   Van Den Bent, Martin ^b   Demmers, Jeroen ^b   Lugtenburg, Pieternella J ^b   Hoogenraad, Casper C ^a,b   Sillevis Smitt, Peter ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DELTA NOTCH LIKE EPIDERMAL GROWTH FACTOR RELATED RECEPTOR; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIRUBICIN; PREDNISONE; PROCARBAZINE; TR ANTIBODY; TR ANTIGEN; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; ATAXIA; CELL ASSAY; CLINICAL ARTICLE; FEMALE; HIPPOCAMPUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; AUTOANTIBODIES; BETA-GALACTOSIDASE; CELL LINE, TRANSFORMED; CHILD; FEMALE; GLYCOSYLATION; HIPPOCAMPUS; HODGKIN DISEASE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; PARANEOPLASTIC CEREBELLAR DEGENERATION; RATS; RECEPTORS, CELL SURFACE; TANDEM REPEAT SEQUENCES; YOUNG ADULT;

EID: 84862774795     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23550     Document Type: Article

References (27)

1. Posner JB. Paraneoplastic syndromes. Philadelphia, PA: F.A. Davis, 1995.
2. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126:1409-1418.
3. Briani C, Vitaliani R, Grisold W, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology 2011;76:705-710.
4. Horwich L, Buxton PH, Ryan GM. Cerebellar degeneration with Hodgkin's disease. J Neurol Neurosurg Psychiatry 1966;29:45-51.
5. Trotter JL, Hendin BA, Osterland CK. Cerebellar degeneration with Hodgkin disease. An immunological study. Arch Neurol 1976;33:660-661.
6. Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
7. Graus F, Gultekin SH, Ferrer I, et al. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system. Acta Neuropathol 1998;96:1-7.
8. Bernal F, Shams'ili S, Rojas I, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003;60:230-234.
9. Keime-Guibert F, Graus F, Broet P, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719-1723.
10. Eiraku M, Hirata Y, Takeshima H, et al. Delta/Notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons. J Biol Chem 2002;277:25400-25407.
11. Hoogenraad CC, Feliu-Mojer MI, Spangler SA, et al. Liprinalpha1 degradation by calcium/calmodulin-dependent protein kinase II regulates LAR receptor tyrosine phosphatase distribution and dendrite development. Dev Cell 2007;12:587-602.
12. Hammack J, Kotanides H, Rosenblum MK, et al. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 1992;42:1938-1943.
13. Furneaux HM, Rosenblum MK, Dalmau J, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-1851.
14. Nishizumi H, Komiyama T, Miyabayashi T, et al. BET, a novel neuronal transmembrane protein with multiple EGF-like motifs. Neuroreport 2002;13:909-915.
15. Sillevis Smitt P, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 2000;342:21-27.
16. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
17. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
18. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
19. Lancaster E, Martinez-Hernandez E, Titulaer MJ, et al. Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology 2011;77:1698-1701.
20. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
21. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655-1667.
22. Graus F, Dalmou J, Rene R, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-2872.
23. de Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. Oncologist 2006;11:292-305.
24. Tohgo A, Eiraku M, Miyazaki T, et al. Impaired cerebellar functions in mutant mice lacking DNER. Mol Cell Neurosci 2006;31:326-333.
25. Eiraku M, Tohgo A, Ono K, et al. DNER acts as a neuron-specific Notch ligand during Bergmann glial development. Nat Neurosci 2005;8:873-880.
26. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-340.
27. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-5875.